Newsroom

Press Release

PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

NeoGenomics to Participate In Two Upcoming Investor Conferences

NeoGenomics Reports Revenue of $63.4 Million, Net Income of $0.6 Million and Adjusted EBITDA of $9.2 Million in the First Quarter of 2018

NeoGenomics Schedules its First Quarter Earnings Release for May 1, 2018

NeoGenomics Announces Executive Appointments

NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2017 Earnings Release for February 21, 2018

NeoGenomics Announces Six Clinical Data Presentations to be Made at the American Society of Hematology Meeting

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients